BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 1826039)

  • 1. Inhibition of cell colony formation by selenite: involvement of glutathione.
    Caffrey PB; Frenkel GD
    Mol Pharmacol; 1991 Mar; 39(3):281-4. PubMed ID: 1826039
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of intracellular glutathione on selenite-mediated growth inhibition of canine mammary tumor cells.
    Kuchan MJ; Milner JA
    Cancer Res; 1992 Mar; 52(5):1091-5. PubMed ID: 1737367
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence for the involvement of sulfhydryl compounds in the inhibition of cellular DNA synthesis by selenite.
    Frenkel GD; Falvey D
    Mol Pharmacol; 1988 Oct; 34(4):573-7. PubMed ID: 3173336
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of selenium compounds and thiols on human mammary tumor cells.
    Yan L; Yee JA; Boylan LM; Spallholz JE
    Biol Trace Elem Res; 1991 Aug; 30(2):145-62. PubMed ID: 1723886
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Products of the reaction of selenite with intracellular sulfhydryl compounds.
    Frenkel GD; Falvey D; MacVicar C
    Biol Trace Elem Res; 1991 Jul; 30(1):9-18. PubMed ID: 1718373
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glutathione depletion by L-buthionine sulfoximine antagonizes taxol cytotoxicity.
    Liebmann JE; Hahn SM; Cook JA; Lipschultz C; Mitchell JB; Kaufman DC
    Cancer Res; 1993 May; 53(9):2066-70. PubMed ID: 8097674
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selenite-induced inhibition of colony formation by buthionine sulfoximine-sensitive and resistant cell lines.
    Caffrey PB; Frenkel GD
    Biol Trace Elem Res; 1992 Nov; 35(2):129-36. PubMed ID: 1280979
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of cell attachment by selenite.
    Yan L; Frenkel GD
    Cancer Res; 1992 Oct; 52(20):5803-7. PubMed ID: 1394206
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Buthionine sulfoximine induction of gamma-L-glutamyl-L-cysteine synthetase gene expression, kinetics of glutathione depletion and resynthesis, and modulation of carmustine-induced DNA-DNA cross-linking and cytotoxicity in human glioma cells.
    Ali-Osman F; Antoun G; Wang H; Rajagopal S; Gagucas E
    Mol Pharmacol; 1996 Jun; 49(6):1012-20. PubMed ID: 8649339
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of D,L-buthionine-S,R-sulfoximine on cytotoxicity and DNA cross-linking induced by bifunctional DNA-reactive cytostatic drugs in human melanoma cells.
    Hansson J; Edgren M; Ehrsson H; Ringborg U; Nilsson B
    Cancer Res; 1988 Jan; 48(1):19-26. PubMed ID: 3334994
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of glutathione depletion by L-buthionine sulfoximine on the cytotoxicity of cyclophosphamide in single and fractionated doses to EMT6/SF mouse tumors and bone marrow.
    Ono K; Shrieve DC
    J Natl Cancer Inst; 1987 Oct; 79(4):811-5. PubMed ID: 3477662
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mitomycin C sensitivity in human bladder cancer cells: possible role of glutathione and glutathione transferase in resistance.
    Xu BH; Gupta V; Singh SV
    Arch Biochem Biophys; 1994 Jan; 308(1):164-70. PubMed ID: 8311448
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selenocompounds induce a redox modulation of protein kinase C in the cell, compartmentally independent from cytosolic glutathione: its role in inhibition of tumor promotion.
    Gopalakrishna R; Chen ZH; Gundimeda U
    Arch Biochem Biophys; 1997 Dec; 348(1):37-48. PubMed ID: 9390172
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Augmentation of cytostatic effect of recombinant human lymphotoxin and involvement of glutathione redox cycle.
    Matsunaga K; Mashiba H
    Eur Cytokine Netw; 1992; 3(3):307-11. PubMed ID: 1498261
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulation of glutathione level in cultured human melanoma cells.
    Karg E; Brötell H; Rosengren E; Rorsman H
    Acta Derm Venereol; 1989; 69(2):137-41. PubMed ID: 2564231
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of glutathione in lymphocyte activation. I. Comparison of inhibitory effects of buthionine sulfoximine and 2-cyclohexene-1-one by nuclear size transformation.
    Hamilos DL; Wedner HJ
    J Immunol; 1985 Oct; 135(4):2740-7. PubMed ID: 4031498
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potentiation of doxorubicin cytotoxicity by buthionine sulfoximine in multidrug-resistant human breast tumor cells.
    Dusre L; Mimnaugh EG; Myers CE; Sinha BK
    Cancer Res; 1989 Feb; 49(3):511-5. PubMed ID: 2535960
    [TBL] [Abstract][Full Text] [Related]  

  • 18. State of sulfhydryl in selenite cataract.
    David LL; Shearer TR
    Toxicol Appl Pharmacol; 1984 Jun; 74(1):109-15. PubMed ID: 6729815
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selenite cytotoxicity in drug resistant and nonresistant human ovarian tumor cells.
    Caffrey PB; Frenkel GD
    Cancer Res; 1992 Sep; 52(17):4812-6. PubMed ID: 1511444
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Buthionine sulfoximine enhances glutathione-but attenuates glutamate-stimulated cell proliferation.
    Kang YJ
    Cell Mol Biol Res; 1995; 41(2):131-6. PubMed ID: 8581064
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.